Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INFUNASDAQ:KRMDNASDAQ:OBIOOTCMKTS:PEYE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINFUInfuSystem$6.21+1.8%$5.36$4.61▼$9.97$130.51M1.8198,702 shs129,455 shsKRMDKORU Medical Systems$3.23+0.9%$2.72$1.86▼$5.05$149.04M0.43135,260 shs85,725 shsOBIOOrchestra BioMed$3.09-2.2%$2.86$2.37▼$8.87$118.39M0.64170,513 shs152,513 shsPEYEPrecision Optics$0.00$1.61▼$2.69$32.98M0.419,793 shs113,500 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINFUInfuSystem+0.16%+2.87%+6.09%+9.91%-14.57%KRMDKORU Medical Systems0.00%+9.59%-0.31%+15.52%+36.17%OBIOOrchestra BioMed-0.32%+3.61%+7.48%-22.55%-60.20%PEYEPrecision Optics0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationINFUInfuSystem2.397 of 5 stars2.03.00.00.01.14.21.9KRMDKORU Medical Systems3.3309 of 5 stars3.55.00.00.02.12.50.6OBIOOrchestra BioMed3.0771 of 5 stars4.63.00.00.02.70.80.0PEYEPrecision OpticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINFUInfuSystem 4.00Strong Buy$13.00109.34% UpsideKRMDKORU Medical Systems 3.00Buy$4.5039.32% UpsideOBIOOrchestra BioMed 3.20Buy$14.20359.55% UpsidePEYEPrecision Optics 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PEYE, KRMD, OBIO, and INFU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00 ➝ $20.005/8/2025INFUInfuSystemB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.505/5/2025OBIOOrchestra BioMedBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$16.00 ➝ $12.004/23/2025OBIOOrchestra BioMedHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy4/22/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00 ➝ $20.004/4/2025OBIOOrchestra BioMedHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$14.00 ➝ $12.004/3/2025OBIOOrchestra BioMedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/1/2025OBIOOrchestra BioMedChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00 ➝ $20.003/20/2025OBIOOrchestra BioMedBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.003/18/2025INFUInfuSystemSidotiSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINFUInfuSystem$137.58M0.95$0.49 per share12.79$2.47 per share2.51KRMDKORU Medical Systems$35.08M4.25N/AN/A$0.45 per share7.18OBIOOrchestra BioMed$2.89M41.02N/AN/A$1.90 per share1.63PEYEPrecision Optics$15.68M0.00N/AN/A$0.53 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINFUInfuSystem$870K$0.14103.5220.03N/A1.12%2.78%1.41%N/AKRMDKORU Medical Systems-$13.74M-$0.11N/AN/AN/A-37.42%-24.60%-16.87%8/6/2025 (Estimated)OBIOOrchestra BioMed-$49.12M-$1.78N/AN/AN/A-2,179.33%-107.04%-70.88%N/APEYEPrecision Optics-$930K-$0.06N/AN/AN/A-5.93%-12.10%-6.41%N/ALatest PEYE, KRMD, OBIO, and INFU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025OBIOOrchestra BioMed-$0.46-$0.49-$0.03-$0.49$0.39 million$0.87 million5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 million3/31/2025Q4 2024OBIOOrchestra BioMed-$0.43-$0.43N/A-$0.43$0.79 million$0.25 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINFUInfuSystemN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/AOBIOOrchestra BioMedN/AN/AN/AN/AN/APEYEPrecision OpticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINFUInfuSystem0.501.981.59KRMDKORU Medical Systems0.012.992.37OBIOOrchestra BioMedN/A4.234.21PEYEPrecision Optics0.231.420.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINFUInfuSystem71.13%KRMDKORU Medical Systems58.60%OBIOOrchestra BioMed53.55%PEYEPrecision OpticsN/AInsider OwnershipCompanyInsider OwnershipINFUInfuSystem11.40%KRMDKORU Medical Systems20.60%OBIOOrchestra BioMed8.10%PEYEPrecision Optics22.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINFUInfuSystem41021.02 million19.10 millionOptionableKRMDKORU Medical Systems8046.14 million34.10 millionOptionableOBIOOrchestra BioMed438.31 million35.47 millionNot OptionablePEYEPrecision Optics8016.92 million13.08 millionNot OptionablePEYE, KRMD, OBIO, and INFU HeadlinesRecent News About These CompaniesLaCroix Precision Optics Expanding Manufacturing Operations in BatesvilleJune 9, 2025 | armoneyandpolitics.comTag: LaCroix Precision OpticsJune 6, 2025 | talkbusiness.netLaCroix Precision Optics expanding in Batesville, adding 107 jobsJune 6, 2025 | talkbusiness.netLaCroix Precision Optics announces $13.8M expansion, creating 107 jobs in BatesvilleJune 6, 2025 | msn.comPrecision Optics Corporation Third Quarter 2025 Earnings: US$0.30 loss per share (vs US$0.052 loss in 3Q 2024)May 17, 2025 | uk.finance.yahoo.comPrecision Optics Corporation, Inc. (NASDAQ:POCI) Q3 2025 Earnings Call TranscriptMay 17, 2025 | msn.comQ3 2025 Precision Optics Corporation Inc Earnings CallMay 16, 2025 | uk.finance.yahoo.comPrecision Optics Enters into Main Purchase Agreement with Top Tier Aerospace Customer and Expands Program Backlog to $6.6 MillionApril 3, 2025 | manilatimes.netPrecision Optics appoints Joseph Pellegrino to board of directorsMarch 21, 2025 | markets.businessinsider.comRochester Precision Optics looks global with $50M funding commitmentMarch 5, 2025 | optics.orgPrecision Optics Corporation, Inc. (NASDAQ:POCI) Q2 2025 Earnings Call TranscriptFebruary 17, 2025 | msn.comPrecision Optics Corporation Second Quarter 2025 Earnings: US$0.15 loss per share (vs US$0.13 loss in 2Q 2024)February 15, 2025 | finance.yahoo.comPrecision Optics Corporation: Precision Optics Reports Second Quarter Fiscal Year 2025 Financial ResultsFebruary 15, 2025 | finanznachrichten.dePrecision Optics Corporation, Inc. (POCI) Q2 2025 Earnings Call TranscriptFebruary 14, 2025 | seekingalpha.comQ2 2025 Precision Optics Corporation Inc Earnings CallFebruary 14, 2025 | finance.yahoo.comPrecision Optics launches endoscopic platformJanuary 28, 2025 | msn.comPrecision Optics Corporation And 2 More Promising US Penny StocksNovember 13, 2024 | finance.yahoo.comNew Spectral Camera Uses AI to Boost Farm Yields by 20%November 6, 2024 | msn.comMicro Eyewear Inc.: Making Eyeglasses That Bring Clarity to See Future OpportunitiesNovember 5, 2024 | msn.comTiny eye movements are the key to making your vision sharperOctober 30, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePEYE, KRMD, OBIO, and INFU Company DescriptionsInfuSystem NYSE:INFU$6.21 +0.11 (+1.80%) Closing price 04:00 PM EasternExtended Trading$6.22 +0.01 (+0.16%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.KORU Medical Systems NASDAQ:KRMD$3.23 +0.03 (+0.94%) Closing price 04:00 PM EasternExtended Trading$3.22 0.00 (-0.15%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.Orchestra BioMed NASDAQ:OBIO$3.09 -0.07 (-2.22%) Closing price 04:00 PM EasternExtended Trading$3.10 +0.01 (+0.32%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.Precision Optics OTCMKTS:PEYEPrecision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
